Extrapulmonary TB in Belarus - Stop TBC · Urogenital TB . CNS TB • Henadz Hurevich – director • Andrey Astrauko – deputy director, monitoring & evaluation department •

Post on 05-Aug-2020

2 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

Transcript

Extrapulmonary TB in Belarus

A.Skrahina

RSPC of Pulmonology and Tuberculosis, Minsk, Belarus

NRL TB units

2nd Level Laboratory

M&E Dep-t

Republican TB Hospital

1st Level Laboratory

3rd Level Laboratory

Oblast TB Dispens.

Regional TB Dispens.

SNRL

ECDC

TB service in Belarus

TB incidence (per 100 000 population), trends, 2002-2012

TB forms distribution (%), trends, 2002-2012

Bacteriological confirmation (%) by all methods, trends, 2002 – 2012

Proportion of MDR-TB among bacteriologically confirmed new TB cases (%), trends, 2010-2012

Proportion of MDR-TB among bacteriologically confirmed relapse cases (%), trends, 2010-2012

Major site of EPTB, trends, 2009-2012

0,7

40,7

7,95,816,3

6,7

19,1

2,62010

EPTB Pulmonary TB

Male/female distribution (%) among new cases, trends, 2010 – 2012

Male/female distribution (%) among relapse cases, trends, 2010 – 2012

EPTB Pulmonary TB

Proportion of HIV co-infected among new cases (%), trends, 2010 – 2012

EPTB Pulmonary TB

Proportion of HIV co-infected among relapse cases (%), trends, 2010 – 2012

EPTB Pulmonary TB

Final outcomes (%): HIV-negative new TB cases, trends, 2010 - 2011

Pulmonary TB

EPTB

Final outcomes (%): HIV-negative relapse cases, trends, 2010 - 2011

Pulmonary TB

EPTB

Final outcomes (%): HIV-positive new TB cases, trends, 2010 - 2011

Pulmonary TB

EPTB

Final outcomes (%): HIV-positive relapse cases, trends, 2010 - 2011

Pulmonary TB

EPTB

• Absence of national EPTB guidelines

• No collaboration between TB specialists and other specialists: – TB is not considered in the differential diagnosis

– Late diagnostics

– Under diagnostics

– Over diagnostics (inability to exclude TB)

– Incidental diagnostics

– Samples from non-TB hospitals are not send to TB lab

• Low level of bacteriologic confirmation: – Unknown drug resistance/susceptibility profile

– Inadequate chemotherapy

Challenges

Pleural TB

Liver and spleen TB

Liver and spleen TB

Spine TB

LN TB

LN TB

Urogenital TB

CNS TB

• Henadz Hurevich – director

• Andrey Astrauko – deputy director, monitoring & evaluation department

• Anna Belko – sr. researcher of monitoring & evaluation department

RSPC of Pulmonology and Tuberculosis, Minsk, Belarus

Acknowledgement

Thanks

top related